144 related articles for article (PubMed ID: 34929248)
1. Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling.
Li Y; Li P; He Q; Zhang R; Li Y; Kamar N; Peppelenbosch MP; de Man RA; Wang L; Pan Q
Antiviral Res; 2022 Jan; 197():105228. PubMed ID: 34929248
[TBL] [Abstract][Full Text] [Related]
2. FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis.
Qu C; Li Y; Li Y; Yu P; Li P; Donkers JM; van de Graaf SFJ; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2019 Oct; 170():104588. PubMed ID: 31415805
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
4. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
5. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers.
Nan Y; Ma Z; Kannan H; Stein DA; Iversen PI; Meng XJ; Zhang YJ
Antiviral Res; 2015 Aug; 120():134-9. PubMed ID: 26086884
[TBL] [Abstract][Full Text] [Related]
7. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
Todt D; Friesland M; Moeller N; Praditya D; Kinast V; Brüggemann Y; Knegendorf L; Burkard T; Steinmann J; Burm R; Verhoye L; Wahid A; Meister TL; Engelmann M; Pfankuche VM; Puff C; Vondran FWR; Baumgärtner W; Meuleman P; Behrendt P; Steinmann E
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1731-1741. PubMed ID: 31896581
[TBL] [Abstract][Full Text] [Related]
8. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication.
Wang W; Wang Y; Debing Y; Zhou X; Yin Y; Xu L; Herrera Carrillo E; Brandsma JH; Poot RA; Berkhout B; Neyts J; Peppelenbosch MP; Pan Q
Antiviral Res; 2017 Apr; 140():1-12. PubMed ID: 28077314
[TBL] [Abstract][Full Text] [Related]
9. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
10. The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models.
Miao Z; Zhang R; Yu P; Li Y; Pan Q; Li Y
Int J Antimicrob Agents; 2021 Sep; 58(3):106383. PubMed ID: 34157403
[TBL] [Abstract][Full Text] [Related]
11. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
12. Progesterone-Mediated Enhancement of Hepatitis E Virus Replication in Human Liver Cells.
Sooryanarain H; Ahmed SA; Meng XJ
mBio; 2021 Jun; 12(3):e0143421. PubMed ID: 34154410
[TBL] [Abstract][Full Text] [Related]
13. Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.
Wu X; Dao Thi VL; Liu P; Takacs CN; Xiang K; Andrus L; Gouttenoire J; Moradpour D; Rice CM
Gastroenterology; 2018 Feb; 154(3):663-674.e7. PubMed ID: 29277559
[TBL] [Abstract][Full Text] [Related]
14. Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90.
Nimgaonkar I; Archer NF; Becher I; Shahrad M; LeDesma RA; Mateus A; Caballero-Gómez J; Berneshawi AR; Ding Q; Douam F; Gaska JM; Savitski MM; Kim H; Ploss A
Antiviral Res; 2021 Jan; 185():104997. PubMed ID: 33326835
[TBL] [Abstract][Full Text] [Related]
15. Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101.
Anang S; Kaushik N; Hingane S; Kumari A; Gupta J; Asthana S; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068652
[TBL] [Abstract][Full Text] [Related]
16. Spicatoside A derived from Liriope platyphylla root ethanol extract inhibits hepatitis E virus genotype 3 replication in vitro.
Park G; Parveen A; Kim JE; Cho KH; Kim SY; Park BJ; Song YJ
Sci Rep; 2019 Mar; 9(1):4397. PubMed ID: 30867434
[TBL] [Abstract][Full Text] [Related]
17. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
18. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
[TBL] [Abstract][Full Text] [Related]
19. Screening of novel drugs for inhibiting hepatitis E virus replication.
Nishiyama T; Kobayashi T; Jirintai S; Kii I; Nagashima S; Prathiwi Primadharsini P; Nishizawa T; Okamoto H
J Virol Methods; 2019 Aug; 270():1-11. PubMed ID: 31004661
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial electron transport chain complex III sustains hepatitis E virus replication and represents an antiviral target.
Qu C; Zhang S; Wang W; Li M; Wang Y; van der Heijde-Mulder M; Shokrollahi E; Hakim MS; Raat NJH; Peppelenbosch MP; Pan Q
FASEB J; 2019 Jan; 33(1):1008-1019. PubMed ID: 30070932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]